Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

POTP

Point Therapeutics (MM) (POTP)

Point Therapeutics (MM)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:POTP
DatumZeitQuelleÜberschriftSymbolFirma
12/02/200822h15PR Newswire (US)DARA BioSciences, Inc. and Point Therapeutics, Inc. Announce Consummation of MergerNASDAQ:POTPPoint Therapeutics (MM)
12/02/200821h02Edgar (US Regulatory)Point Therapeutics Inc - Amended Statement of Ownership (SC 13G/A)NASDAQ:POTPPoint Therapeutics (MM)
11/02/200820h30Edgar (US Regulatory)Point Therapeutics Inc - Current report filing (8-K)NASDAQ:POTPPoint Therapeutics (MM)
11/02/200815h00Business WireUpdate on Point Therapeutics Merger with DARA BioSciencesNASDAQ:POTPPoint Therapeutics (MM)
08/02/200816h23Edgar (US Regulatory)Point Therapeutics Inc-Filing of certain prospectuses & communications for business combination transactions (425)NASDAQ:POTPPoint Therapeutics (MM)
04/02/200814h36Edgar (US Regulatory)Point Therapeutics Inc-Filing of certain prospectuses & communications for business combination transactions (425)NASDAQ:POTPPoint Therapeutics (MM)
04/02/200813h30PR Newswire (US)DARA BioSciences to Present at the ROTH Growth Stock ConferenceNASDAQ:POTPPoint Therapeutics (MM)
29/01/200822h30Business WirePoint Therapeutics Adjourns Meeting of Stockholders to February 12, 2008; DARA BioSciences Stockholders Approve Merger with PoinNASDAQ:POTPPoint Therapeutics (MM)
17/01/200812h03Edgar (US Regulatory)Point Therapeutics Inc-Filing of certain prospectuses & communications for business combination transactions (425)NASDAQ:POTPPoint Therapeutics (MM)
10/01/200820h07Edgar (US Regulatory)Point Therapeutics Inc - Current report filing (8-K)NASDAQ:POTPPoint Therapeutics (MM)
10/01/200814h00Business WirePoint Therapeutics Receives Additional Notice of Non-Compliance from NASDAQNASDAQ:POTPPoint Therapeutics (MM)
27/12/200721h45Edgar (US Regulatory)Point Therapeutics Inc - Current report filing (8-K)NASDAQ:POTPPoint Therapeutics (MM)
27/12/200721h43Edgar (US Regulatory)Point Therapeutics Inc-Filing of certain prospectuses & communications for business combination transactions (425)NASDAQ:POTPPoint Therapeutics (MM)
27/12/200714h30Business WirePoint Therapeutics Announces Form S-4 Registration Statement Declared Effective by SEC; Special Meeting of Stockholders Set forNASDAQ:POTPPoint Therapeutics (MM)
18/12/200718h55Edgar (US Regulatory)Point Therapeutics Inc - Current report filing (8-K)NASDAQ:POTPPoint Therapeutics (MM)
17/12/200723h12Edgar (US Regulatory)Point Therapeutics Inc - Registration Statement for securities to be issued in business combination transactions (S-4/A)NASDAQ:POTPPoint Therapeutics (MM)
17/12/200719h17Edgar (US Regulatory)Point Therapeutics Inc - Current report filing (8-K)NASDAQ:POTPPoint Therapeutics (MM)
17/12/200714h30Business WireNASDAQ Panel Grants Request of Point Therapeutics for Continued Listing on NASDAQ Capital MarketNASDAQ:POTPPoint Therapeutics (MM)
26/11/200713h13Edgar (US Regulatory)Point Therapeutics Inc - Securities Registration: Business Combination (S-4)NASDAQ:POTPPoint Therapeutics (MM)
19/11/200718h36Edgar (US Regulatory)Point Therapeutics Inc - Current report filing (8-K)NASDAQ:POTPPoint Therapeutics (MM)
09/11/200715h59Edgar (US Regulatory)Point Therapeutics Inc - Current report filing (8-K)NASDAQ:POTPPoint Therapeutics (MM)
09/11/200715h38Edgar (US Regulatory)Point Therapeutics Inc - Quarterly Report (10-Q)NASDAQ:POTPPoint Therapeutics (MM)
25/10/200713h00PR Newswire (US)DARA BioSciences, Inc. Announces New Board ChairmanNASDAQ:POTPPoint Therapeutics (MM)
17/10/200713h00PR Newswire (US)DARA BioSciences and Bayer Pharmaceuticals Corporation Sign Exclusive License AgreementNASDAQ:POTPPoint Therapeutics (MM)
18/09/200721h36Edgar (US Regulatory)Point Therapeutics Inc - Current report filing (8-K)NASDAQ:POTPPoint Therapeutics (MM)
09/08/200722h01Business WirePoint Therapeutics Reports Second Quarter 2007 Financial ResultsNASDAQ:POTPPoint Therapeutics (MM)
27/07/200713h30Business WirePoint Therapeutics Announces Further Management ReductionsNASDAQ:POTPPoint Therapeutics (MM)
12/07/200714h30Business WirePoint Therapeutics UpdateNASDAQ:POTPPoint Therapeutics (MM)
31/05/200714h00Business WirePoint Therapeutics Reduces Costs by Cutting Work ForceNASDAQ:POTPPoint Therapeutics (MM)
21/05/200714h00Business WireTalabostat Clinical Program Put on Clinical Hold by FDANASDAQ:POTPPoint Therapeutics (MM)
 Showing the most relevant articles for your search:NASDAQ:POTP

Kürzlich von Ihnen besucht